What You Should Know: Nearly three-fourths of life sciences organizations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia®. Over half of these organizations (53%) still center their operations around legacy software systems primarily for basic image viewing despite growing adoption of artificial intelligence (AI) to accelerate the introduction of breakthrough therapeutics.The “2023
Read More
Digital Pathology
PathAI and ConcertAI Partner to Create Histopathology & Clinical RWD Solutions
What You Should Know: PathAI, a provider of AI-powered pathology, and ConcertAI, an AI software-as-a-service (SaaS) technology and real-world evidence (RWE) solutions for life sciences and healthcare, today announced a strategic partnership to launch a first-in-class quantitative histopathology and curated clinical real-world data (RWD) solution.The solution combines PathAI's PathExplore™ tumor microenvironment panel with ConcertAI's Patient360™ and RWD360™
Read More
Spectrum Taps Proscia to Modernize its Pathology Operations
- Proscia®, a leading provider of digital and computational pathology solutions, today announced that Spectrum Healthcare Partners (SHCP), an independent, multispecialty, physician-owned healthcare practice, has selected Concentriq® Dx to modernize its pathology operations. In adopting Proscia’s software platform, SHCP will increase access to high-quality diagnostic services across Maine and New Hampshire, better informing treatment decisions for more patients. - Digital pathology, which
Read More
Clarapath Acquires AI-Powered Digital Pathology Platform Crosscope
What You Should Know: - Clarapath, a robotics company aimed at catalyzing change in the way pathology laboratories process human and animal tissue acquires Mountain View, CA-based Crosscope. Financial details of the acquisition were not disclosed. - Crosscope is a digital pathology company with a turnkey imaging solution providing best-in-class workflow tools and slide management along with artificial intelligence (AI) and machine learning (ML) technology to assist pathologists with better
Read More
PathGroup Expands Operations with Proscia Concentriq Dx
What You Should Know: - PathGroup, one of the largest providers of anatomic, clinical, digital, and molecular pathology services in the United States, is expanding its operations with Proscia's software platform (Concentriq® Dx) to further enhance the delivery of faster, higher quality results for millions of patients, helping to better inform treatment decisions. - PathGroup currently supports more than 15,000 referring physicians and over 200 hospital
Read More
Develop, Partner, Acquire or Avoid – Where’s Investment for Digital Pathology Headed in 2023?
News of Fujifilm’s recent acquisition of software provider Inspirata’s digital pathology assets was met with much interest last month, following on from robust industry debate at Global Engage’s Digital Pathology and AI Congress: Europe a few weeks prior. Their discussions centered around the progress of the market and its inevitable future developments. Whilst our in-depth analysis of the implications of Fujifilm’s specific deal will be released soon as a part of our Premium Insights
Read More
Netherlands Cancer Institute to Deploy Proscia’s Pathology Platform
What You Should Know: - Proscia®, a provider of digital and computational pathology solutions, announced that the Netherlands Cancer Institute (NKI), one of the top 10 comprehensive cancer centers in Europe, will deploy its Concentriq® Dx platform. - NKI is transitioning to Concentriq Dx to expand its digital pathology practice, laying the foundation for its pathologists to deliver personalized diagnoses that better inform treatment decisions. In doing so, the cancer center,
Read More
Research: Proscia AI Predicts Diagnostic Agreement for Melanoma
What You Should Know: - Proscia® a provider of digital and computational pathology solutions, has released study results on new artificial intelligence (AI) that predicts diagnostic agreement for melanoma, the deadliest form of skin cancer. - The findings, which were presented at the European Conference on Computer Vision (ECCV) 2022, highlight the potential of the technology to improve diagnostic accuracy for melanoma and other diseases with low pathologist concordance. Findings
Read More
Proscia Unveils New Enhancements to its Digital Pathology Platform
What You Should Know: - Proscia®, a leading provider of digital and computational pathology solutions, has introduced the next version of its Concentriq® Dx platform for primary diagnostic workflows, which is CE-marked under IVDR. - The release brings together new features and a compelling user experience to help even the largest laboratory networks transition to 100% digital diagnosis. In doing so, they can realize the full promise of the shift away from microscope-based
Read More
KLAS: State of Digital Pathology Among Early Adopters in 2022
What You Should Know: - In anticipation, many technology vendors are vying for a foothold in the US, leading to a highly varied landscape. In partnership with the Digital Pathology Association (DPA), KLAS surveyed 55 provider organizations (including hospitals, health systems, academic health centers, and reference labs) to assess the state of digital pathology among pioneers in the US and determine which vendors are gaining traction. - 33 of the interviewed organizations are live with
Read More
